Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multiple sclerosis: potential risk factors in childhood and adolescence.
Frequency of myasthenia gravis in multiple sclerosis: Report of five cases from Isfahan, Iran.
[Therapeutic development for neuromyelitis optica].
C-C chemokine receptor type 4 antagonist Compound 22 ameliorates experimental autoimmune encephalomyelitis.
Using mental visual imagery to improve autobiographical memory and episodic future thinking in relapsing-remitting multiple sclerosis patients: A randomised-controlled trial study.
Neuromyelitis Optica (NMO) with Abdominal Tuberculosis (TB).
Vitamin D and multiple sclerosis-from epidemiology to prevention.
An aza-anthrapyrazole negatively regulates Th1 activity and suppresses experimental autoimmune encephalomyelitis.
[Collaborative networks between Spain and Latin America regarding multiple sclerosis].
Neurological disorders and celiac disease.
Need for differentiation of real and clinical important change in research on responsiveness of walking outcome measures in multiple sclerosis.
Successful antiviral treatment of chronic hepatitis C in patients with rare comorbidities. Two case-reports.
Acute disseminated encephalomyelitis in two renal transplant patients: is there a role for Epstein-Barr virus reactivation?
Relapsing Remitting Multiple Sclerosis in an Iranian Patient with Neurofibromatosis Type I.
Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system.
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data.
Prevalence of Anti-JC Virus Antibody in Multiple Sclerosis Patients in Kuwait.
Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort.
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis.
Molecular mechanisms linking neuroinflammation and neurodegeneration in MS.
Adult neurogenesis and neurodegenerative diseases: A systems biology perspective.
Proteomics Urine Analysis of Pregnant Women Suffering from Multiple Sclerosis.
Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition.
Uphill and Downhill Walking in Multiple Sclerosis: A Randomized Controlled Trial.
Application of metabolomics in autoimmune diseases: Insight into biomarkers and pathology.
Pages
« first
‹ previous
…
652
653
654
655
656
657
658
659
660
…
next ›
last »